CA Patent

CA2082495C — A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols

Assigned to Lyfjathroun Hf Biopharmaceuticals · Expires 2006-10-03 · 20y expired

What this patent protects

A pharmaceutical preparation for application of biologically active substance(s) to a mucosal membrane of a mammal comprising one or more substance(s) selected from the group consisting of n-glycofurols represented by formula (I), wherein n is 1 to 8, and n-ethylene glycols repre…

USPTO Abstract

A pharmaceutical preparation for application of biologically active substance(s) to a mucosal membrane of a mammal comprising one or more substance(s) selected from the group consisting of n-glycofurols represented by formula (I), wherein n is 1 to 8, and n-ethylene glycols represented by the formula (II): H(OCH2CH2)p OH, wherein p is 1 to 14, produces a high plasma concentration of the pharmaceutically active substance(s) nearly as rapid as by i.v. administration.

Drugs covered by this patent

Patent Metadata

Patent number
CA2082495C
Jurisdiction
CA
Classification
—
Expires
2006-10-03
Drug substance claim
No
Drug product claim
No
Assignee
Lyfjathroun Hf Biopharmaceuticals
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.